Month: February 2019
-
Blood Test as Good as Biopsy to Detect Cancer Targets
Results of a clinical trial show a commercial blood test works at least as well as tissue biopsies for determining precise genetic mutations causing most lung cancers.
-
Housing Your Business In A Safe Space
In this post, we are going to take a look at what you can do to ensure that the building is actually a safe space for your business to operate.
-
Anti-Inflammatory Human Protein Produced in Plants
Researchers in Canada genetically engineered tobacco plants to economically produce large quantities of a human protein with anti-inflammatory properties.
-
Trials Underway Testing Crispr for Blood Disorders
Clinical trials testing the genome editing technique Crispr for sickle cell disease and beta thalassemia, two inherited blood disorders, enrolled and infused their first patients.
-
Change The Workplace Environment To Boost Productivity
When it comes to employee productivity, it’s not just about the individual, but the environment in which they work.
-
Gene Editing Deactivates Cause of T-Cell Side Effects
A biotechnology company developing engineered T-cells as treatments for cancer, used gene editing to deactivate a likely cause of serious adverse effects from its therapies.
-
Organoids Designed for Faster Cancer Diagnostics
A new process grows small samples of tumor tissue in the lab to enable high-speed diagnostics for personalized cancer treatments and drug testing.
-
What Patients Can Teach You About Your Health Facility
– Contributed content – 16 Feb. 2019. In an ideal world, no patient would ever complain at your health care facility. You want to help people, after all, and every patient should leave with a smile on their faces. Sadly, as surgeries become more overwhelmed, this is happening less often. The majority of health care…
-
FDA Drafts Brain-Computer Device Regulatory Guidance
Food and Drug Administration is releasing for comment regulatory guidance for its review of implanted medical devices that connect human brains to computer systems.
-
Gene Therapy Company Acquired in $4.3B Deal
Spark Therapeutics, a biotechnology company that pioneered gene therapies, is being acquired by drug maker Roche Group in a deal valued at $4.3 billion.